Celgene Corporation (CELG) Position Reduced by Suntrust Banks Inc

Mindy Sparks
December 7, 2017

Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC. Motco now owns 822 shares of the biopharmaceutical company's stock valued at $102,000 after buying an additional 620 shares in the last quarter. The stock decreased 0.38% or $0.39 during the last trading session, reaching $102.17. About 1.63M shares traded. Washington Real Estate Investment Trust (WRE) has risen 15.41% since December 7, 2016 and is uptrending. Finally, Oppenheimer set a $166.00 price objective on shares of Celgene and gave the stock a "buy" rating in a report on Thursday, November 16th. Horan Cap Advsr Limited Liability Corporation owns 28,009 shares for 2.47% of their portfolio. Twenty First Centy Fox Inc now has $59.14 billion valuation. (NYSE:CEI) traded down -3.44% in the last session while performance was up 0.16% in the last five days. About 31.17M shares traded.

A number of analysts offered their Estimated Earnings analysis for Celgene Corporation (CELG) for the current quarter. It has outperformed by 0.30% the S&P500. The stock of Celgene Corporation (NASDAQ:CELG) earned "Market Outperform" rating by JMP Securities on Wednesday, March 9. Therefore 34% are positive. The stock of Celgene Corporation (NASDAQ:CELG) has "Underweight" rating given on Thursday, October 5 by Morgan Stanley. The rating was maintained by Citigroup on Friday, November 10 with "Buy". Finally, Piper Jaffray Companies reissued a neutral rating and issued a $133.00 price target on shares of Celgene in a research note on Monday, October 23rd. The firm has "Outperform" rating given on Wednesday, August 12 by Cowen & Co. On Wednesday, July 26 the stock rating was maintained by RBC Capital Markets with "Hold". The stock of JPMorgan Chase & Co. It shows the cash a company is able to generate after spending the money need to maintain or grow its asset base. The company was maintained on Wednesday, February 24 by Jefferies.

Investors sentiment increased to 1.15 in 2017 Q2. Its up 0.14, from 1.05 in 2017Q1. It increased, as 82 investors sold AT&T Inc. shares while 619 reduced holdings. 146 funds opened positions while 731 raised stakes. 7,049 are held by Edgewood Llc. Jacobus Wealth Mgmt accumulated 2,089 shares or 0.07% of the stock. King Luther Mgmt holds 0% of its portfolio in Ford Motor Company (NYSE:F) for 22,250 shares. Colonial Tru Advisors owns 100,737 shares or 2.09% of their U.S. portfolio. Bp Plc holds 112,000 shares. Korea Investment reported 865,755 shares. Alliancebernstein Lp stated it has 0% in Federated Investors, Inc. Mirae Asset Global Com invested in 1.04% or 459,360 shares.

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a company's financial position.

Analysts await JPMorgan Chase & Co. Cibc Ww Mkts owns 204,143 shares.

Ims Capital Management decreased Federated Invs Inc Pa (FII) stake by 24.04% reported in 2017Q2 SEC filing. It also upped Service Corp Intl (NYSE:SCI) stake by 23,389 shares and now owns 526,177 shares. Conagra Inc Com (NYSE:CAG) was reduced too. $1.16M worth of Celgene Corporation (NASDAQ:CELG) was sold by CASEY MICHAEL D. Therefore 65% are positive. Histogenics Corp had 14 analyst reports since August 27, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Celgene Corporation (NASDAQ:CELG) on Monday, August 28 with "Buy" rating. $16's average target is -15.35% below currents $18.9016 stock price. Jefferies Group LLC reaffirmed a "buy" rating and set a $154.00 price objective on shares of Celgene in a research report on Tuesday, April 11th. Illinois-based Envestnet Asset Management has invested 0.06% in Celgene Corporation (NASDAQ:CELG). If the published price targets set by Celgene Corporation analysts have any power to influence the stock's share price, the highest price target set for CELG is $166. Oppenheimer maintained it with "Buy" rating and $17500 target in Thursday, July 27 report. The rating was initiated by Suntrust Robinson with "Buy" on Thursday, January 7. The firm has a market capitalization of $81,060.00, a PE ratio of 16.03, a PEG ratio of 0.79 and a beta of 1.77. Wells Fargo & Company MN raised its position in shares of Crispr Therapeutics by 459.7% in the second quarter. The biopharmaceutical company reported $1.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.47 by $0.21. Cullinan Associate stated it has 0.65% of its portfolio in Celgene Corporation (NASDAQ:CELG). British Columbia Management Corporation holds 529,992 shares or 0.55% of its portfolio. Friedman Michael A had sold 5,000 shares worth $625,000 on Saturday, June 17. Sectoral Asset Mngmt owns 233,768 shares. The shares went up by 0.52% in value last month. Also, Director Gilla Kaplan sold 9,250 shares of the stock in a transaction on Tuesday, September 12th. Martin Invest Management Lc holds 113,304 shares. During the same period in the previous year, the company earned $1.58 earnings per share. Wells Fargo Mn owns 7.02M shares or 0.29% of their USA portfolio. Chicago Equity Prns Llc holds 0.32% or 91,740 shares. Columbia Asset Management invested 0.25% in Celgene Corporation (NASDAQ:CELG). Philadelphia Tru Com holds 0.5% in Celgene Corporation (NASDAQ:CELG) or 44,956 shares. Appleton Incorporated Ma holds 12,062 shares or 0.26% of its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article